IQE PLC IQE plc: Total Voting Rights (1405U)
01 Agosto 2022 - 10:00AM
UK Regulatory
TIDMIQE
RNS Number : 1405U
IQE PLC
01 August 2022
IQE plc
Total Voting Rights
Cardiff, UK
1 August 2022
("IQE" or the "Company")
Total Voting Rights
As at 31 July 2022, the Company's issued share capital consisted
of 804,638,414 ordinary shares of 1 pence each ("Ordinary Shares").
The Company holds 4,115 Ordinary Shares in treasury. Therefore the
total number Ordinary Shares with voting rights in the Company is
804,634,299.
Shareholders may use this figure (804,634,299) as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.
Contacts:
IQE plc
+44 (0) 29 2083 9400
Amy Barlow
Peel Hunt LLP (Nomad and Broker)
+44 (0) 20 7418 8900
Edward Knight
Paul Gillam
James Smith
Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
ABOUT IQE
http://iqep.com
IQE is the leading global supplier of advanced compound
semiconductor wafers and materials solutions that enable a diverse
range of applications across:
-- handset devices
-- global telecoms infrastructure
-- connected devices
-- 3D Sensing
As a scaled global epitaxy wafer manufacturer, IQE is uniquely
positioned in this market which has high barriers to entry. IQE
supplies the whole market and is agnostic to the winners and losers
at chip and OEM level. By leveraging the Group's intellectual
property portfolio including know-how and patents, it produces
epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with c. 685 employees across
nine manufacturing locations in the UK, US, Taiwan and Singapore,
and is listed on the AIM Stock Exchange in London.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRXVLFLLDLZBBK
(END) Dow Jones Newswires
August 01, 2022 11:00 ET (15:00 GMT)
Iqe (LSE:IQE)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Iqe (LSE:IQE)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024